Effects of ACE2 inhibition in the post-myocardial infarction heart

Journal of Cardiac Failure

Volumn 16, Issue 9, 2010, Pages 777-785

  Kim, Myung A ^a,b   Yang, Dongheon ^b   Kida, Keisuke ^b,c   Molotkova, Natalia ^b   Yeo, Seon Ju ^b   Varki, Nissi ^d   Iwata, Michikado ^b   Dalton, Nancy D ^b   Peterson, Kirk L ^b   Siems, Wolf Eberhard ^e   Walther, Thomas ^f,g   Cowling, Randy T ^b   Kjekshus, John ^b,h   Greenberg, Barry ^b  

^a Seoul National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^f UNIVERSITY OF HULL   (United Kingdom)

^g JUSTUS LIEBIG UNIVERSITY   (Germany)

^h UNIVERSITY OF OSLO   (Norway)

Author keywords

Angiotensin converting enzyme 2 (ACE2); c kit+ stem cells; C16; cardiac remodeling; renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; C 16; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART PROTECTION; HEART VENTRICLE REMODELING; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; APOPTOSIS; CORONARY VESSELS; FIBROSIS; HEART SEPTUM; HEART VENTRICLES; HEMODYNAMICS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; TIME FACTORS;

EID: 77956184446     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2010.04.002     Document Type: Article

References (49)

1. G.G. Serneri, M. Boddi, I. Cecioni, S. Vanni, M. Coppo, and M.L. Papa Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function Circ Res 88 2001 961 968
2. N. Sharpe Cardiac remodeling in congestive heart failure J.D. Hosenpud, B.H. Greenberg, Congestive heart failure Second ed 2000 Lippincott Williams & Wilkins Philadelphia 101 115
3. K.T. Weber Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation Circulation 96 1997 4065 4082
4. D.E. Dostal, and K.M. Baker The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function? Circ Res 85 1999 643 650
5. N.N. Kim, F.J. Villarreal, M.P. Printz, A.A. Lee, and W.H. Dillmann Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts Am J Physiol 269 1995 E426 E437
6. S. Kim, K. Ohta, A. Hamaguchi, T. Yukimura, K. Miura, and H. Iwao Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats Hypertension 25 1995 1252 1259
7. J.M. Pfeffer, M.A. Pfeffer, P.J. Fletcher, and E. Braunwald Progressive ventricular remodeling in rat with myocardial infarction Am J Physiol 260 1991 H1406 H1414
8. K.T. Weber, and Y. Sun Remodeling of the cardiac interstitium in ischemic cardiomyopathy J.D. Hosenpud, B.H. Greenberg, Congestive heart failure Second ed 2000 Lippincott Williams & Wilkins Philadelphia 117 136
9. J.M. Pfeffer, M.A. Pfeffer, and E. Braunwald Influence of chronic captopril therapy on the infarcted left ventricle of the rat Circ Res 57 1985 84 95
10. M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown Jr., and T.E. Cuddy Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators [see comments] N Engl J Med 327 1992 669 677
11. B. Greenberg, M.A. Quinones, C. Koilpillai, M. Limacher, D. Shindler, and C. Benedict Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy Circulation 91 1995 2573 2581
12. L.M. Burrell, C.I. Johnston, C. Tikellis, and M.E. Cooper ACE2, a new regulator of the renin-angiotensin system Trends Endocrinol Metab 15 2004 166 169
13. M. Donoghue, F. Hsieh, E. Baronas, K. Godbout, M. Gosselin, and N. Stagliano A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 Circ Res 87 2000 E1 E9
14. M.A. Crackower, R. Sarao, G.Y. Oudit, C. Yagil, I. Kozieradzki, and S.E. Scanga Angiotensin-converting enzyme 2 is an essential regulator of heart function Nature 417 2002 822 828
15. S.R. Tipnis, N.M. Hooper, R. Hyde, E. Karran, G. Christie, and A.J. Turner A human homolog of angiotensin-converting enzyme-cloning and functional expression as a captopril-insensitive carboxypeptidase J Biol Chem 275 2000 33238 33243
16. D. Harmer, M. Gilbert, R. Borman, and K.L. Clark Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme FEBS Lett 532 2002 107 110
17. C. Vickers, P. Hales, V. Kaushik, L. Dick, J. Gavin, and J. Tang Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase J Biol Chem 277 2002 14838 14843
18. L.S. Zisman, G.E. Meixell, M.R. Bristow, and C.C. Canver Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate Circulation 108 2003 1679 1681
19. K.B. Brosnihan, P. Li, and C.M. Ferrario Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide Hypertension 27 1996 523 528
20. E.J. Freeman, G.M. Chisolm, C.M. Ferrario, and E.A. Tallant Angiotensin-(1-7) inhibits vascular smooth muscle cell growth Hypertension 28 1996 104 108
21. M. Iwata, R.T. Cowling, D. Gurantz, C. Moore, S. Zhang, and J.X. Yuan Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects Am J Physiol Heart Circ Physiol 289 2005 H2356 H2363
22. W.B. Strawn, C.M. Ferrario, and E.A. Tallant Angiotensin-(1-7) reduces smooth muscle growth after vascular injury Hypertension 33 1999 207 211
23. E.A. Tallant, C.M. Ferrario, and P.E. Gallagher Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor Am J Physiol Heart Circ Physiol 289 2005 H1560 H1566
24. S.B. Gurley, A. Allred, T.H. Le, R. Griffiths, L. Mao, and N. Philip Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice J Clin Invest 116 2006 2218 2225
25. J. Ambrose, D.G. Pribnow, G.D. Giraud, K.D. Perkins, L. Muldoon, and B.H. Greenberg Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle J Cardiovasc Pharmacol 33 1999 433 439
26. D. Gurantz, R.T. Cowling, N. Varki, E. Frikovsky, C.D. Moore, and B.H. Greenberg IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart J Mol Cell Cardiol 38 2005 505 515
27. N.A. Dales, A.E. Gould, J.A. Brown, E.F. Calderwood, B. Guan, and C.A. Minor Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors J Am Chem Soc 124 2002 11852 11853
28. M.A. Pfeffer, and E. Braunwald Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1990 1161 1172
29. M.A. Pfeffer, G.A. Lamas, D.E. Vaughan, A.F. Parisi, and E. Braunwald Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction N Engl J Med 319 1988 80 86
30. L. Kober, C. Torp-Pedersen, J.E. Carlsen, H. Bagger, P. Eliasen, and K. Lyngborg A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group N Engl J Med 333 1995 1670 1676
31. H. Jin, R. Yang, T.A. Awad, F. Wang, W. Li, and S.P. Williams Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction Circulation 103 2001 736 742
32. S. Mankad, T.A. d'Amato, N. Reichek, W.E. McGregor, J. Lin, and D. Singh Combined angiotensin II receptor antagonism and angiotensin-converting enzyme inhibition further attenuates postinfarction left ventricular remodeling Circulation 103 2001 2845 2850
33. Z. Zhu, J. Zhong, S. Zhu, D. Liu, G.M. Van Der, and M. Tepel Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction J Cardiovasc Pharmacol 40 2002 693 700
34. J. Kajstura, W. Cheng, K. Reiss, W.A. Clark, E.H. Sonnenblick, and S. Krajewski Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats Lab Invest 74 1996 86 107
35. A.P. Beltrami, L. Barlucchi, D. Torella, M. Baker, F. Limana, and S. Chimenti Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776
36. K. Guan, and G. Hasenfuss Do stem cells in the heart truly differentiate into cardiomyocytes? J Mol Cell Cardiol 43 2007 377 387
37. D. Orlic, J. Kajstura, S. Chimenti, F. Limana, I. Jakoniuk, and F. Quaini Mobilized bone marrow cells repair the infarcted heart, improving function and survival Proc Natl Acad Sci U S A 98 2001 10344 10349
38. L.S. Zisman, R.S. Keller, B. Weaver, Q. Lin, R. Speth, and M.R. Bristow Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2 Circulation 108 2003 1707 1712
39. V.S. Lemos, D.M. Silva, T. Walther, N. Alenina, M. Bader, and R.A. Santos The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice J Cardiovasc Pharmacol 46 2005 274 279
40. R. Masson, S.A. Nicklin, M.A. Craig, M. McBride, K. Gilday, and P. Gregorevic Onset of experimental severe cardiac fibrosis is mediated by overexpression of angiotensin-converting enzyme 2 Hypertension 53 2009 694 700
41. K. Yamamoto, M. Ohishi, T. Katsuya, N. Ito, M. Ikushima, and M. Kaibe Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II Hypertension 47 2006 718 726
42. S. Der Sarkissian, J.L. Grobe, L. Yuan, D.R. Narielwala, G.A. Walter, and M.J. Katovich Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology Hypertension 51 2008 712 718
43. M.J. Huentelman, J.L. Grobe, J. Vazquez, J.M. Stewart, A.P. Mecca, and M.J. Katovich Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats Exp Physiol 90 2005 783 790
44. L.M. Burrell, J. Risvanis, E. Kubota, R.G. Dean, P.S. MacDonald, and S. Lu Myocardial infarction increases ACE2 expression in rat and humans Eur Heart J 26 2005 369 375
45. A.B. Goulter, M.J. Goddard, J.C. Allen, and K.L. Clark ACE2 gene expression is up-regulated in the human failing heart BMC Med 2 2004 19
46. S. Epelman, W.H. Tang, S.Y. Chen, L.F. Van, G.S. Francis, and S. Sen Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin- aldosterone system J Am Coll Cardiol 52 2008 750 754
47. E.A. Tallant, and P.E. Gallagher Angiotensin-(1-7) upregulates the mitogen-activated phosphatase DUSP1 in vascular smooth muscle cells Hypertension 50 2007 e77
48. E.A. Tallant, C.M. Ferrario, and P.E. Gallagher Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor Am J Physiol Heart Circ Physiol 289 2005 H1560 H1566
49. A.E. Loot, A.J. Roks, R.H. Henning, R.A. Tio, A.J. Suurmeijer, and F. Boomsma Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats Circulation 105 2002 1548 1550